Other Long-term Investments of Elevance Health, Inc. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term investments classified as other.
Summary
Elevance Health, Inc. quarterly Other Long-term Investments in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • Elevance Health, Inc. Other Long-term Investments for the quarter ending 31 Dec 2025 was $10,839,000,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Other Long-term Investments, Quarterly (USD)
Other Long-term Investments, YoY Quarterly Change (%)

Elevance Health, Inc. Quarterly Other Long-term Investments (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $10,839,000,000 +$1,090,000,000 +11% 31 Dec 2025 10-K 06 Feb 2026 2025 FY
Q3 2025 $10,648,000,000 +$1,254,000,000 +13% 30 Sep 2025 10-Q 21 Oct 2025 2025 Q3
Q2 2025 $10,466,000,000 +$3,656,000,000 +54% 30 Jun 2025 10-Q 17 Jul 2025 2025 Q2
Q1 2025 $10,167,000,000 +$3,454,000,000 +51% 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 $9,749,000,000 +$3,642,000,000 +60% 31 Dec 2024 10-K 06 Feb 2026 2025 FY
Q3 2024 $9,394,000,000 +$3,276,000,000 +54% 30 Sep 2024 10-Q 17 Oct 2024 2024 Q3
Q2 2024 $6,810,000,000 +$817,000,000 +14% 30 Jun 2024 10-Q 17 Jul 2024 2024 Q2
Q1 2024 $6,713,000,000 +$742,000,000 +12% 31 Mar 2024 10-Q 18 Apr 2024 2024 Q1
Q4 2023 $6,107,000,000 +$422,000,000 +7.4% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q3 2023 $6,118,000,000 +$602,000,000 +11% 30 Sep 2023 10-Q 18 Oct 2023 2023 Q3
Q2 2023 $5,993,000,000 +$595,000,000 +11% 30 Jun 2023 10-Q/A 29 Sep 2023 2023 Q2
Q1 2023 $5,971,000,000 +$606,000,000 +11% 31 Mar 2023 10-Q 19 Apr 2023 2023 Q1
Q4 2022 $5,685,000,000 +$460,000,000 +8.8% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q3 2022 $5,516,000,000 +$557,000,000 +11% 30 Sep 2022 10-Q 19 Oct 2022 2022 Q3
Q2 2022 $5,398,000,000 +$481,000,000 +9.8% 30 Jun 2022 10-Q 20 Jul 2022 2022 Q2
Q1 2022 $5,365,000,000 +$891,000,000 +20% 31 Mar 2022 10-Q 20 Apr 2022 2022 Q1
Q4 2021 $5,225,000,000 +$940,000,000 +22% 31 Dec 2021 10-Q 18 Oct 2023 2023 Q3
Q3 2021 $4,959,000,000 +$789,000,000 +19% 30 Sep 2021 10-Q 20 Oct 2021 2021 Q3
Q2 2021 $4,917,000,000 +$820,000,000 +20% 30 Jun 2021 10-Q 21 Jul 2021 2021 Q2
Q1 2021 $4,474,000,000 +$293,000,000 +7% 31 Mar 2021 10-Q 21 Apr 2021 2021 Q1
Q4 2020 $4,285,000,000 +$27,000,000 +0.63% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $4,170,000,000 +$256,000,000 +6.5% 30 Sep 2020 10-Q 28 Oct 2020 2020 Q3
Q2 2020 $4,097,000,000 +$378,000,000 +10% 30 Jun 2020 10-Q 29 Jul 2020 2020 Q2
Q1 2020 $4,181,000,000 +$471,000,000 +13% 31 Mar 2020 10-Q 29 Apr 2020 2020 Q1
Q4 2019 $4,258,000,000 +$532,000,000 +14% 31 Dec 2019 10-K 18 Feb 2021 2020 FY
Q3 2019 $3,914,000,000 +$342,000,000 +9.6% 30 Sep 2019 10-Q 23 Oct 2019 2019 Q3
Q2 2019 $3,719,000,000 +$223,800,000 +6.4% 30 Jun 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 $3,710,000,000 +$249,200,000 +7.2% 31 Mar 2019 10-Q 24 Apr 2019 2019 Q1
Q4 2018 $3,726,000,000 +$382,000,000 +11% 31 Dec 2018 10-K 19 Feb 2020 2019 FY
Q3 2018 $3,572,000,000 +$1,129,900,000 +46% 30 Sep 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 $3,495,200,000 +$1,143,100,000 +49% 30 Jun 2018 10-Q 25 Jul 2018 2018 Q2
Q1 2018 $3,460,800,000 +$1,173,500,000 +51% 31 Mar 2018 10-Q 25 Apr 2018 2018 Q1
Q4 2017 $3,344,000,000 +$1,103,500,000 +49% 31 Dec 2017 10-K 20 Feb 2019 2018 FY
Q3 2017 $2,442,100,000 +$286,200,000 +13% 30 Sep 2017 10-Q 25 Oct 2017 2017 Q3
Q2 2017 $2,352,100,000 +$264,000,000 +13% 30 Jun 2017 10-Q 26 Jul 2017 2017 Q2
Q1 2017 $2,287,300,000 +$209,000,000 +10% 31 Mar 2017 10-Q 26 Apr 2017 2017 Q1
Q4 2016 $2,240,500,000 +$199,400,000 +9.8% 31 Dec 2016 10-K 21 Feb 2018 2017 FY
Q3 2016 $2,155,900,000 +$317,600,000 +17% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $2,088,100,000 +$284,800,000 +16% 30 Jun 2016 10-Q 27 Jul 2016 2016 Q2
Q1 2016 $2,078,300,000 +$359,900,000 +21% 31 Mar 2016 10-Q 27 Apr 2016 2016 Q1
Q4 2015 $2,041,100,000 +$345,200,000 +20% 31 Dec 2015 10-K 22 Feb 2017 2016 FY
Q3 2015 $1,838,300,000 +$146,500,000 +8.7% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $1,803,300,000 +$125,200,000 +7.5% 30 Jun 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 $1,718,400,000 +$124,600,000 +7.8% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 $1,695,900,000 +$153,300,000 +9.9% 31 Dec 2014 10-K 19 Feb 2016 2015 FY
Q3 2014 $1,691,800,000 +$175,000,000 +12% 30 Sep 2014 10-Q 29 Oct 2014 2014 Q3
Q2 2014 $1,678,100,000 +$167,700,000 +11% 30 Jun 2014 10-Q 30 Jul 2014 2014 Q2
Q1 2014 $1,593,800,000 +$111,400,000 +7.5% 31 Mar 2014 10-Q 30 Apr 2014 2014 Q1
Q4 2013 $1,542,600,000 +$155,000,000 +11% 31 Dec 2013 10-K 24 Feb 2015 2013 FY
Q3 2013 $1,516,800,000 +$280,700,000 +23% 30 Sep 2013 10-Q 23 Oct 2013 2013 Q3
Q2 2013 $1,510,400,000 +$319,200,000 +27% 30 Jun 2013 10-Q 24 Jul 2013 2013 Q2
Q1 2013 $1,482,400,000 +$441,100,000 +42% 31 Mar 2013 10-Q 24 Apr 2013 2013 Q1
Q4 2012 $1,387,600,000 +$284,300,000 +26% 31 Dec 2012 10-K 20 Feb 2014 2013 FY
Q3 2012 $1,236,100,000 +$231,800,000 +23% 30 Sep 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 $1,191,200,000 +$245,500,000 +26% 30 Jun 2012 10-Q 25 Jul 2012 2012 Q2
Q1 2012 $1,041,300,000 +$129,600,000 +14% 31 Mar 2012 10-Q 25 Apr 2012 2012 Q1
Q4 2011 $1,103,300,000 +$237,900,000 +27% 31 Dec 2011 10-K 22 Feb 2013 2012 FY
Q3 2011 $1,004,300,000 +$159,200,000 +19% 30 Sep 2011 10-Q 26 Oct 2011 2011 Q3
Q2 2011 $945,700,000 +$123,200,000 +15% 30 Jun 2011 10-Q 27 Jul 2011 2011 Q2
Q1 2011 $911,700,000 +$109,300,000 +14% 31 Mar 2011 10-Q 27 Apr 2011 2011 Q1
Q4 2010 $865,400,000 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 $845,100,000 30 Sep 2010 10-Q 03 Nov 2010 2010 Q3
Q2 2010 $822,500,000 30 Jun 2010 10-Q/A 03 Aug 2010 2010 Q2
Q1 2010 $802,400,000 31 Mar 2010 10-Q 28 Apr 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.